New Information on EBV Role
- A new study suggests a possible link between the reactivation of the Epstein-Barr virus (EBV) following a SARS-CoV-2 infection and the progress of multi-system inflammatory syndrome in children...
- While most children experience mild symptoms from a COVID-19 infection, some develop complications like MIS-C, also known as pediatric inflammatory multisystem syndrome (PIMS).
- Researchers in Germany have published findings in the journal Nature suggesting a potential explanation.
Study Links COVID-19, Epstein-Barr Virus Reactivation to MIS-C in Children
Table of Contents
- Study Links COVID-19, Epstein-Barr Virus Reactivation to MIS-C in Children
- Study Links COVID-19, Epstein-Barr virus Reactivation to MIS-C in Children: Your Questions Answered
- What is MIS-C and Why Is This Research Crucial?
- What is the Epstein-Barr Virus (EBV)?
- What Is the Connection Between EBV and COVID-19?
- what is Multi-System Inflammatory Syndrome in Children (MIS-C)?
- What are the Symptoms of MIS-C?
- What Did the German Researchers Find in Their Study?
- What is TGF-beta and Why Is It Important?
- Study findings: MIS-C vs. COVID-19 Without MIS-C
- What Dose This Mean for Treatment?
A new study suggests a possible link between the reactivation of the Epstein-Barr virus (EBV) following a SARS-CoV-2 infection and the progress of multi-system inflammatory syndrome in children (MIS-C), a rare but serious condition. This interplay between the two viruses has also been observed in cases of Long COVID.
MIS-C: A Rare COVID-19 Complication
While most children experience mild symptoms from a COVID-19 infection, some develop complications like MIS-C, also known as pediatric inflammatory multisystem syndrome (PIMS). The underlying cause of MIS-C had previously remained unclear.
German Researchers Find Potential Description
Researchers in Germany have published findings in the journal Nature suggesting a potential explanation. The study indicated that children with MIS-C showed not onyl the presence of EBV but also an excessive immune response to the virus.
MIS-C Symptoms and Prevalence
MIS-C typically appears four to eight weeks after a COVID-19 infection in children and adolescents, especially affecting elementary school-aged children (approximately 6-12 years old), with a slightly higher incidence in boys. Symptoms include fever, rashes, and cardiovascular involvement, perhaps leading to heart failure, myocarditis, and pericarditis. Roughly half of MIS-C patients require intensive care to prevent organ failure, with treatment often involving anti-inflammatory medications like steroids.
Estimates suggest that MIS-C occurred in approximately one out of 800 children after infection with the original COVID-19 virus. However, sence the dominance of Omicron variants in 2021, the risk has decreased to about one in 4,000 children.
The clinical presentation of MIS-C can vary depending on the child’s age. In infants and younger children, it resembles kawasaki disease, while older children may exhibit symptoms similar to toxic shock syndrome (TSS).
Epstein-Barr virus and COVID-19 Connection
The Epstein-barr virus, a member of the herpes virus family, often manifests as mononucleosis (infectious mononucleosis) during the initial infection. After infection,the virus persists in the body and can reactivate under certain conditions. Approximately 95% of adults worldwide have been infected with EBV, frequently enough during childhood.
Previous research has suggested a link between EBV and COVID-19, with some studies indicating that EBV reactivation may be associated with long-term impairments like fatigue following a SARS-CoV-2 infection.
Additional research has pointed to circulating EBV antibodies and persistent activation of the complement system in Long COVID patients. ther is also evidence suggesting a connection between EBV and autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis.
Study Details and Findings
The research team, led by Prof. Dr. Tillmann Kallinich from the German Rheumatism Research Center (DRFZ), examined 145 children between the ages of two and 18 who were treated at five European centers. They discovered traces of EBV reactivation, high concentrations of anti-EBV antibodies, and EBV-specific immune cells in the blood of MIS-C patients.
In contrast, 105 children with COVID-19 infection but without MIS-C showed lower EBV seroprevalence and no EBV-specific signs of inflammation, suggesting that thier immune systems were actively attempting to eliminate the virus.
Furthermore, the serum of the children with MIS-C exhibited unusually high levels of transforming growth factor beta (TGF-beta), an inflammatory mediator known for its anti-inflammatory effects. In these children, TGF-beta appeared to dampen the function of virus-specific memory T cells. The researchers suggest that TGF-beta could be preventing the immune system from effectively fighting EBV, potentially prolonging the infection and contributing to MIS-C.
Potential Therapeutic Target
The researchers propose that the underlying cause of MIS-C may involve both EBV infection and a misdirected immune response to the SARS-CoV-2 infection, leading to overproduction of TGF-beta. They hope that blocking TGF-beta could represent a new therapeutic target for MIS-C.
Source: Nature Journal
Study Links COVID-19, Epstein-Barr virus Reactivation to MIS-C in Children: Your Questions Answered
What is MIS-C and Why Is This Research Crucial?
Multi-system inflammatory syndrome in children (MIS-C) is a rare but serious condition that can develop in children after a COVID-19 infection.A new study suggests a link between MIS-C, the reactivation of the Epstein-Barr virus (EBV), and a misdirected immune response following a SARS-CoV-2 infection. This research is crucial because it offers potential explanations for the underlying causes of MIS-C, which were previously unclear, and suggests new therapeutic targets.
What is the Epstein-Barr Virus (EBV)?
The Epstein-Barr virus (EBV) is a common member of the herpes virus family.It’s a very common virus. After the initial infection, the virus persists in the body and can reactivate under certain conditions.
How common is EBV? Approximately 95% of adults worldwide have been infected wiht EBV, often during childhood.
What are the symptoms of the initial EBV infection? The initial infection with EBV often manifests as mononucleosis (infectious mononucleosis).
What Is the Connection Between EBV and COVID-19?
The study suggests a link between EBV reactivation and the progress of MIS-C following a SARS-CoV-2 infection. Previous research has already suggested a link between EBV and long COVID and autoimmune diseases.
what is Multi-System Inflammatory Syndrome in Children (MIS-C)?
MIS-C, also known as pediatric inflammatory multisystem syndrome (PIMS), is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. It’s a rare complication of a COVID-19 infection.
How Common is MIS-C?
MIS-C is rare,but the incidence has changed over time:
Before the dominance of the Omicron variants,estimates suggested MIS-C occurred in approximately one out of 800 children after infection with the original COVID-19 virus.
As the dominance of Omicron variants in 2021, the risk has decreased to about one in 4,000 children.
What are the Symptoms of MIS-C?
MIS-C typically appears four to eight weeks after a COVID-19 infection in children and adolescents, especially affecting elementary school-aged children (approximately 6-12 years old), with a slightly higher incidence in boys.
Common Symptoms: Fever, rashes, and cardiovascular involvement.This can lead to heart failure as well as myocarditis and pericarditis.
Variations in Presentation:
in infants and younger children, it can resemble Kawasaki disease.
Older children may exhibit symptoms similar to toxic shock syndrome (TSS).
What Did the German Researchers Find in Their Study?
Researchers in Germany have found a potential explanation for the development of MIS-C. Their study,published in the journal nature,found the following:
EBV Reactivation: children with MIS-C showed traces of EBV reactivation in their system.
High Antibody Levels: They had high concentrations of anti-EBV antibodies.
Immune Cell Activity: The presence of EBV-specific immune cells was also high.
Immune Response: Children with MIS-C showed evidence of an excessive immune response to EBV.
* TGF-beta Involvement: The serum (blood) of children with MIS-C had unusually high levels of transforming growth factor beta (TGF-beta), an inflammatory mediator.
What is TGF-beta and Why Is It Important?
Transforming growth factor beta (TGF-beta) is an inflammatory mediator. In children with MIS-C, TGF-beta appeared to dampen the function of virus-specific memory T cells. Researchers suggest TGF-beta could be preventing the immune system from effectively fighting EBV, potentially prolonging the infection and contributing to MIS-C.
Study findings: MIS-C vs. COVID-19 Without MIS-C
A key comparison within the study highlighted the differences between children who developed MIS-C and those who had COVID-19 without developing MIS-C.
Key Differences
| Feature | Children with MIS-C | Children with COVID-19 (No MIS-C) |
| ——————– | ————————————————————– | —————————————————————— |
| EBV Reactivation | present | Lower |
| Anti-EBV Antibodies | High concentrations | Lower seroprevalence |
| EBV-Specific Immune Cells | Present | No EBV-specific signs of inflammation |
| TGF-beta Levels | Unusually high | not specified in this article |
| immune Response | Misdirected immune response to SARS-CoV-2 and EBV | Immune systems attempting to eliminate the virus. |
What Dose This Mean for Treatment?
The researchers propose that blocking TGF-beta could represent a new therapeutic target for MIS-C.They believe the underlying cause of MIS-C may involve both EBV infection and a misdirected immune response to the SARS-CoV-2 infection, leading to the overproduction of TGF-beta.